BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 23300950)

  • 1. FGFR2 promotes breast tumorigenicity through maintenance of breast tumor-initiating cells.
    Kim S; Dubrovska A; Salamone RJ; Walker JR; Grandinetti KB; Bonamy GM; Orth AP; Elliott J; Porta DG; Garcia-Echeverria C; Reddy VA
    PLoS One; 2013; 8(1):e51671. PubMed ID: 23300950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.
    Lo PK; Kanojia D; Liu X; Singh UP; Berger FG; Wang Q; Chen H
    Oncogene; 2012 May; 31(21):2614-26. PubMed ID: 21996747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.
    Hillebrand LE; Bengsch F; Hochrein J; Hülsdünker J; Bender J; Follo M; Busch H; Boerries M; Reinheckel T
    Oncotarget; 2016 Sep; 7(36):58244-58260. PubMed ID: 27542270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of Six1 in luminal breast cancers predicts poor prognosis and promotes increases in tumor initiating cells by activation of extracellular signal-regulated kinase and transforming growth factor-beta signaling pathways.
    Iwanaga R; Wang CA; Micalizzi DS; Harrell JC; Jedlicka P; Sartorius CA; Kabos P; Farabaugh SM; Bradford AP; Ford HL
    Breast Cancer Res; 2012 Jul; 14(4):R100. PubMed ID: 22765220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCG2, a novel antigen to sort luminal progenitors of BRCA1- breast cancer cells.
    Leccia F; Del Vecchio L; Mariotti E; Di Noto R; Morel AP; Puisieux A; Salvatore F; Ansieau S
    Mol Cancer; 2014 Sep; 13():213. PubMed ID: 25216750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mel-18 controls the enrichment of tumor-initiating cells in SP fraction in mouse breast cancer.
    Janakiraman H; Nobukiyo A; Inoue H; Kanno M
    Hiroshima J Med Sci; 2011 Jun; 60(2):25-35. PubMed ID: 21970185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression analysis of mammospheres cultured from human breast cancers.
    Feifei N; Mingzhi Z; Yanyun Z; Huanle Z; Fang R; Mingzhu H; Mingzhi C; Yafei S; Fengchun Z
    J Cancer Res Clin Oncol; 2012 Nov; 138(11):1937-44. PubMed ID: 22752669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Yap1 promotes the survival and self-renewal of breast tumor initiating cells via inhibiting Smad3 signaling.
    Sun JG; Chen XW; Zhang LP; Wang J; Diehn M
    Oncotarget; 2016 Mar; 7(9):9692-706. PubMed ID: 26695440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seventeen-gene signature from enriched Her2/Neu mammary tumor-initiating cells predicts clinical outcome for human HER2+:ERα- breast cancer.
    Liu JC; Voisin V; Bader GD; Deng T; Pusztai L; Symmans WF; Esteva FJ; Egan SE; Zacksenhaus E
    Proc Natl Acad Sci U S A; 2012 Apr; 109(15):5832-7. PubMed ID: 22460789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.
    Schwab LP; Peacock DL; Majumdar D; Ingels JF; Jensen LC; Smith KD; Cushing RC; Seagroves TN
    Breast Cancer Res; 2012 Jan; 14(1):R6. PubMed ID: 22225988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC/PKC-EZR (ezrin) pathway.
    Qureshi-Baig K; Kuhn D; Viry E; Pozdeev VI; Schmitz M; Rodriguez F; Ullmann P; Koncina E; Nurmik M; Frasquilho S; Nazarov PV; Zuegel N; Boulmont M; Karapetyan Y; Antunes L; Val D; Mittelbronn M; Janji B; Haan S; Letellier E
    Autophagy; 2020 Aug; 16(8):1436-1452. PubMed ID: 31775562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncGPR107 drives the self-renewal of liver tumor initiating cells and liver tumorigenesis through GPR107-dependent manner.
    Huang G; Jiang H; Lin Y; Xia W; Luo Y; Wu Y; Cai W; Zhou X; Jiang X
    J Exp Clin Cancer Res; 2018 Jun; 37(1):121. PubMed ID: 29925408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene set enrichment analysis provides insight into novel signalling pathways in breast cancer stem cells.
    Murohashi M; Hinohara K; Kuroda M; Isagawa T; Tsuji S; Kobayashi S; Umezawa K; Tojo A; Aburatani H; Gotoh N
    Br J Cancer; 2010 Jan; 102(1):206-12. PubMed ID: 19997106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
    Rappa G; Lorico A
    Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
    Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
    Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDC20 maintains tumor initiating cells.
    Xie Q; Wu Q; Mack SC; Yang K; Kim L; Hubert CG; Flavahan WA; Chu C; Bao S; Rich JN
    Oncotarget; 2015 May; 6(15):13241-54. PubMed ID: 25938542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A reciprocal regulatory circuit between CD44 and FGFR2 via c-myc controls gastric cancer cell growth.
    Park J; Kim SY; Kim HJ; Kim KM; Choi EY; Kang MS
    Oncotarget; 2016 May; 7(19):28670-83. PubMed ID: 27107424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncMAPK6 drives MAPK6 expression and liver TIC self-renewal.
    Huang G; Jiang H; He Y; Lin Y; Xia W; Luo Y; Liang M; Shi B; Zhou X; Jian Z
    J Exp Clin Cancer Res; 2018 May; 37(1):105. PubMed ID: 29764463
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spheres derived from the human SN12C renal cell carcinoma cell line are enriched in tumor initiating cells.
    Zhang Y; Sun B; Zhao X; Sun H; Cui W; Liu Z; Yao X; Dong X
    J Exp Clin Cancer Res; 2016 Oct; 35(1):163. PubMed ID: 27756344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Characterization of Tumor-Initiating Cells in Multiple Myeloma.
    Gao M; Bai H; Jethava Y; Wu Y; Zhu Y; Yang Y; Xia J; Cao H; Franqui-Machin R; Nadiminti K; Thomas GS; Salama ME; Altevogt P; Bishop G; Tomasson M; Janz S; Shi J; Chen L; Frech I; Tricot G; Zhan F
    J Natl Cancer Inst; 2020 May; 112(5):507-515. PubMed ID: 31406992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.